Drug: NEXAVAR Injury: Hyperkeratosis Quarter: 2016Q3
Total Records: 9 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
113278472 | NEXAVAR | Hyperkeratosis | BAYER | 74.00 YR | M | 0 | 20160823 | US |
123557502 | NEXAVAR | Hyperkeratosis | BAYER | 39.00 YR | F | 0 | 20160712 | MX |
124324762 | NEXAVAR | Hyperkeratosis | BAYER | 52.00 YR | M | 0 | 20160713 | MX |
125499522 | NEXAVAR | Hyperkeratosis | BAYER | 0.00 | M | 0 | 20160721 | CN |
125714263 | NEXAVAR | Hyperkeratosis | BAYER | 77.00 YR | M | 0 | 20160916 | ID |
126294521 | NEXAVAR | Hyperkeratosis | BAYER | 69.00 YR | M | 0 | 20160808 | MX |
127600751 | NEXAVAR | Hyperkeratosis | BAYER | 65.00 YR | M | 0 | 20160919 | GB |
127656981 | NEXAVAR | Hyperkeratosis | FDA-CTU | 0.00 | F | 0 | 20160915 | US |
1185820611 | NEXAVAR | Hyperkeratosis | BAYER | 69.00 YR | M | 69 KG | 20160722 | MX |
Total Records: 9 Number of Pages: 1